Mathilde Romagnoli is an accomplished biomarker strategy leader in oncology at Servier since January 2018, previously serving as a translational research scientist within the same department. In addition, Mathilde is a co-founder and scientific advisor at Adecto Pharmaceuticals. Previous roles include postdoctoral research fellowships at Institut Curie and Tufts University School of Medicine, where notable research focused on breast cancer mechanisms and therapeutic effects of hormone therapy. Mathilde began an academic career as a teaching assistant at Université de Nantes and completed a Ph.D. in hematology-oncology at the same institution, supported by a solid educational background in cellular biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices